Program for childhood cancer survivors to quit smoking

NewsGuard 100/100 Score

As smokers nationwide struggle to quit the habit, St. Jude Children's Research Hospital is offering assistance to those childhood cancer survivors who need help with smoking cessation.

Despite the known health risks of tobacco use, about 18 percent of adults who survived childhood cancer are smokers—an average almost equal to that of the general population. Childhood cancer survivors are more likely to develop second cancers and other conditions such as diabetes, heart disease and stroke. Smoking adds to their health risks.

"The increase in survival rates for childhood cancer has been one of the most significant successes in cancer during the past three decades," said Robert Klesges, Ph.D., of the St. Jude Epidemiology and Cancer Control department. "However, few researchers have addressed the issue of smoking in cancer survivors. Because the population of childhood cancer survivors is growing each year, St. Jude sought an effective way to help these individuals."

In recent years, smoking prevention and cessation efforts in the United States have included public smoking bans, the establishment of toll-free quit lines as well as the Great American Smokeout event organized annually to encourage smokers to quit. This year's event is November 19. To address the unique needs of childhood cancer survivors who smoke, St. Jude created the Cancer Survivor Tobacco Quit Line through a grant from the National Cancer Institute.

Through the quit line, participants are assigned to one of two interventions: a counselor-initiated group or a self-paced group. In the counselor-initiated group, St. Jude counselors call participants six times during an eight-week period. The counselors help participants prepare to quit, set quit dates and help participants avoid relapses. Smokers in the self-paced group receive the same intervention but are responsible for phoning the counselors. All participants receive nicotine-replacement therapy in the form of patches or gum.

"St. Jude has long sought to empower childhood cancer survivors, helping them understand the health risks associated with their treatment as well as providing resources for follow-up care. The quit line is an extension of this philosophy," Klesges said.

St. Jude counselors on the confidential, toll-free line hold advanced degrees and have professional experience in public health. "We personalize the plan to each participant," said Charla Folsom, the study's lead clinical research associate. "We gauge what situations are the hardest for participants and try to create a plan to help with those situations."

Participation in the quit line is free and open to all childhood cancer survivors, regardless of where they received treatment. Study organizers plan to enroll 1,000 participants during the next few years. Childhood cancer survivors can call (877) 4SJ-QUIT, or visit www.stjude.org/breakfreefromsmoking for more information about the tobacco cessation study.

The quit line effort is one of several ongoing St. Jude studies, seeking to improve the quality of life among adults who survived pediatric cancer. St. Jude is also the coordinating institution for the Childhood Cancer Survivor Study (CCSS), a data-gathering program organized by 30 centers in the United States and Canada, studying the late effects of childhood cancer. Information about CCSS studies can be found by visiting http://ccss.stjude.org.

www.stjude.org.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
First FDA-approved cellular therapy for metastatic melanoma available in South Florida